{
    "clinical_study": {
        "@rank": "9735", 
        "arm_group": {
            "arm_group_label": "Urgent(R) PC Neuromodulation System", 
            "arm_group_type": "Experimental", 
            "description": "Urgent(R) PC Neuromodulation System"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the effectiveness of percutaneous tibial nerve\n      stimulation (PTNS) therapy with the Urgent\u00ae PC Neuromodulation System (Uroplasty, Inc.,\n      Minnetonka, MN, USA) for the treatment of fecal incontinence (FI)."
        }, 
        "brief_title": "Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence", 
        "completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Fecal Incontinence", 
        "condition_browse": {
            "mesh_term": "Fecal Incontinence"
        }, 
        "detailed_description": {
            "textblock": "Pilot Study"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient history of chronic FI of more than staining for at least 6 months;  staining\n             defined as less than the size of a 25\u00a2 piece (quarter)\n\n          -  Patient reported and/or failed \u2265 2 conservative therapies (e.g., diet/fiber\n             modification, anti-diarrheal medication, pelvic floor muscle training, biofeedback,\n             medical management, etc.)\n\n        Exclusion Criteria:\n\n          -  Pregnancy or intention to become pregnant during the course of the study\n\n          -  Implanted electro-medical device (i.e., pacemaker, defibrillator, deep brain\n             stimulator, etc.)\n\n          -  Clinically significant neurological diseases or nerve damage impacting tibial nerve\n             or pelvic floor function\n\n          -  Prone to excessive bleeding or bleeding diathesis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01666405", 
            "org_study_id": "UPC032012"
        }, 
        "intervention": {
            "arm_group_label": "Urgent(R) PC Neuromodulation System", 
            "description": "The Urgent PC Neuromodulation System (Uroplasty, Inc., Minnetonka, MN, USA), device, is an easily administered neuromodulation system designed to deliver retrograde access to the sacral nerve through percutaneous electrical stimulation of the tibial nerve. This method of treatment is referred to as percutaneous tibial nerve stimulation (PTNS).", 
            "intervention_name": "Urgent(R) PC Neuromodulation System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Fecal Incontinence", 
            "Bowel Incontinence"
        ], 
        "lastchanged_date": "March 5, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Kaiser Permanente Los Angeles Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "UCSF Center for Colorectal Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55407"
                    }, 
                    "name": "Minnesota Colon and Rectal Surgery Associates, Ltd."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "The Lindner Center for Research and Education at The Christ Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Colorectal Surgical Asociates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Spokane", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "99204"
                    }, 
                    "name": "Providence Health and Services"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "To assess the effectiveness of PTNS by measuring the proportion of patients with \u226550% decrease in the number of fecal incontinence episodes per week based on the results of the 14-day bowel diary at 18 weeks compared to baseline", 
                "measure": "Effectiveness", 
                "safety_issue": "No", 
                "time_frame": "18 weeks"
            }, 
            {
                "description": "To characterize adverse events experienced throughout the study", 
                "measure": "Safety", 
                "safety_issue": "Yes", 
                "time_frame": "18 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01666405"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Uroplasty, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Uroplasty, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}